Article Versions Notes

Hachisu Y, Koga Y, Kasama S, Kaira K, Yatomi M, Aoki-Saito H, Tsurumaki H, Kamide Y, Sunaga N, Maeno T, et al. Treatment with Tumor Necrosis Factor-α Inhibitors, History of Allergy, and Hypercalcemia Are Risk Factors of Immune Reconstitution Inflammatory Syndrome in HIV-Negative Pulmonary Tuberculosis Patients. Journal of Clinical Medicine. 2020; 9(1):96. https://doi.org/10.3390/jcm9010096

Hachisu, Yoshimasa, Yasuhiko Koga, Shu Kasama, Kyoichi Kaira, Masakiyo Yatomi, Haruka Aoki-Saito, Hiroaki Tsurumaki, Yosuke Kamide, Noriaki Sunaga, Toshitaka Maeno, and et al. 2020. "Treatment with Tumor Necrosis Factor-α Inhibitors, History of Allergy, and Hypercalcemia Are Risk Factors of Immune Reconstitution Inflammatory Syndrome in HIV-Negative Pulmonary Tuberculosis Patients" Journal of Clinical Medicine 9, no. 1: 96. https://doi.org/10.3390/jcm9010096

Hachisu, Y., Koga, Y., Kasama, S., Kaira, K., Yatomi, M., Aoki-Saito, H., Tsurumaki, H., Kamide, Y., Sunaga, N., Maeno, T., Ishizuka, T., & Hisada, T. (2020). Treatment with Tumor Necrosis Factor-α Inhibitors, History of Allergy, and Hypercalcemia Are Risk Factors of Immune Reconstitution Inflammatory Syndrome in HIV-Negative Pulmonary Tuberculosis Patients. Journal of Clinical Medicine, 9(1), 96. https://doi.org/10.3390/jcm9010096